These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 1130406)

  • 21. Contamination of intravenous solutions by airborne microbes.
    Hansen JS; Hepler CD
    Am J Hosp Pharm; 1973 Apr; 30(4):326-31. PubMed ID: 4697656
    [No Abstract]   [Full Text] [Related]  

  • 22. Heparin lock: a cost-effective method of increasing safety of intravenous therapy.
    Thomas TL; Heydt S
    J Oral Surg; 1980 Mar; 38(3):221-2. PubMed ID: 6766502
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Monitoring contamination levels of in-use intravenous solutions using "total sample" techniques.
    Hanson AL; Shelley RM
    Am J Hosp Pharm; 1974 Aug; 31(8):733-5. PubMed ID: 4853252
    [No Abstract]   [Full Text] [Related]  

  • 24. ASHP--hospital intravenous admixture program certification.
    Turco S
    Hosp Pharm; 1978 Jun; 13(6):306, 356. PubMed ID: 10307642
    [No Abstract]   [Full Text] [Related]  

  • 25. Particulate inspection of parenteral products: an assessment.
    Knapp JZ; Kushner HK; Abramson LR
    J Parenter Sci Technol; 1981; 35(4):176-85. PubMed ID: 7277132
    [No Abstract]   [Full Text] [Related]  

  • 26. Strategies for the validation of viral inactivation in biologic products.
    Aronson DL
    Prog Clin Biol Res; 1990; 324():137-49. PubMed ID: 2408050
    [No Abstract]   [Full Text] [Related]  

  • 27. [Methods for ensuring the apyrogenic quality of injection solutions in hospital pharmacies].
    Eroshevskiĭ AA; Khveshchuk PF; Riabykh LD
    Voen Med Zh; 1991 Mar; (3):59-60. PubMed ID: 1853599
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The of "laminar air flow" systems].
    Stampf G; Willy K
    Pharmazie; 1984 Sep; 39(9):647-8. PubMed ID: 6505004
    [No Abstract]   [Full Text] [Related]  

  • 29. [Microfilters within the scope of infusion therapy--possibilities and problems in retention of microbial and particle contaminants].
    Bach A; Böttiger BW
    Zentralbl Chir; 1994; 119(4):268-75. PubMed ID: 8203178
    [TBL] [Abstract][Full Text] [Related]  

  • 30. IV lines need nursing care.
    Ballard K; Jacques S
    Nursing (Lond); 1992 Apr 9-22; 5(7):6. PubMed ID: 1579294
    [No Abstract]   [Full Text] [Related]  

  • 31. Depyrogenation of a parenteral solution by ultrafiltration.
    Abramson D; Butler LD; Chrai S
    J Parenter Sci Technol; 1981; 35(1):3-7. PubMed ID: 7229828
    [No Abstract]   [Full Text] [Related]  

  • 32. Sterility-testing program for antibiotics and other intravenous admixtures.
    Choy FN; Lamy PP; Burkhart VD; Tenney JH
    Am J Hosp Pharm; 1982 Mar; 39(3):452-6. PubMed ID: 7041640
    [No Abstract]   [Full Text] [Related]  

  • 33. Worldwide perspective in transfusion safety: Europe.
    Reesink HW; Strengers PE
    Dev Biol (Basel); 2000; 102():205-10. PubMed ID: 10794107
    [No Abstract]   [Full Text] [Related]  

  • 34. Integrity testing of vial closure systems used for parenteral products.
    Frieben WR; Folck RJ; Devisser A
    J Parenter Sci Technol; 1982; 36(3):112-6. PubMed ID: 7097453
    [No Abstract]   [Full Text] [Related]  

  • 35. Aseptic methods for removing fluids from small-volume parenterals.
    Nagata RE; Mock ED; Reynolds G; Moriyama W; Schalker WL
    Hosp Pharm; 1977 Mar; 12(3):118-9, 122-6. PubMed ID: 10235811
    [No Abstract]   [Full Text] [Related]  

  • 36. An approach to establishing parenteral solution sterilization cycles.
    Korczynski MS; Peterson CL; Loshbaugh CC
    Bull Parenter Drug Assoc; 1974; 28(6):270-7. PubMed ID: 4455323
    [No Abstract]   [Full Text] [Related]  

  • 37. Method for testing aseptic technique of intravenous admixture personnel.
    Dirks I; Smith FM; Furtado D; White SJ; Godwin HN
    Am J Hosp Pharm; 1982 Mar; 39(3):457-9. PubMed ID: 7041641
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [What lessons are to be learned? Quality of animal vaccines].
    Wensing CJ
    Tijdschr Diergeneeskd; 2001 Mar; 126(6):230. PubMed ID: 11285647
    [No Abstract]   [Full Text] [Related]  

  • 39. Hepatitis C and immune globulin.
    Prince AM; Horowitz B
    N Engl J Med; 1995 May; 332(18):1236; author reply 1236-7. PubMed ID: 7700325
    [No Abstract]   [Full Text] [Related]  

  • 40. Particulate inspection of parenteral products: from biophysics to automation.
    Knapp JZ; Kushner HK
    J Parenter Sci Technol; 1982; 36(3):121-7. PubMed ID: 7097455
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.